Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
---|
10/10/2006 | US7119206 drugs such as 12-[4-(2-Piperidin-1-yl-ethoxy)-phenyl]-7,12-dihydro-benzo[a]anthracene-3,9-diol, used for prevention of bone and cardiovascular disorders, as hypotensive, thrombolytic and anticholesterol agents |
10/10/2006 | US7119198 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents |
10/10/2006 | US7118899 Introducing a reagent comprising a hydrophobic fluorescent ion; measuring energy transfer |
10/10/2006 | CA2268799C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same |
10/05/2006 | WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors |
10/05/2006 | US20060223995 Superhigh purity ionic liquid |
10/05/2006 | US20060223836 New phenylalanine derivatives |
10/05/2006 | US20060223726 Photo-labile pro-fragrance conjugates |
10/05/2006 | CA2603122A1 Phenyl and pyridyl lta4h modulators |
10/04/2006 | EP1706371A1 Aryl aniline derivatives as beta2 adrenergic receptor agonists |
10/04/2006 | EP1451194B1 Preparation of levofloxacin hemihydrate |
10/03/2006 | US7115780 For therapy of ulcers, pancreatitis, obesity, urinary incontinence and pollakiuria |
10/03/2006 | US7115750 Melanin concentrating hormone antagonist |
10/03/2006 | US7115646 Cyclic diamines and derivatives as factor Xa inhibitors |
09/28/2006 | WO2006101009A1 Nile red-based red luminescent compound, and luminescent element using the same |
09/28/2006 | WO2006047503A3 Inhibitors of c-fms kinase |
09/28/2006 | WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds |
09/28/2006 | WO2004070352A3 Methods, mixtures, kits and compositions pertaining to analyte determination |
09/28/2006 | US20060217550 One pot process; cyclization; 4-(4-nitrophenyl)-3-oxomorpholine; Factor Xa inhibitors; , myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty and claudicatio intermittens |
09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
09/26/2006 | US7112586 Substituted diamine derivatives useful as motilin antagonists |
09/26/2006 | US7112584 Antiinflammatory agents; antiarthritic agents; antiallergens; antiinflammatory agents |
09/21/2006 | WO2006067587A3 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
09/21/2006 | US20060211860 Compounds for the treatment of Alzheimer's disease |
09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
09/21/2006 | US20060211657 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
09/21/2006 | US20060211097 Process for producing enantiopure beta-amino acid derivatives, and enantiopure beta-amino acid derivatives |
09/21/2006 | CA2600468A1 Stabilized compositions of volatile alkylating agents and methods of using thereof |
09/20/2006 | EP1701724A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
09/20/2006 | CN1835911A Novel method for synthesizing esters of N-[(S)-1-carboxybutyl]-(S)-alanine and use thereof for synthesizing perindopril |
09/19/2006 | US7109153 Photo-labile pro-fragrance conjugates |
09/14/2006 | WO2006094994A1 Use of 4-aminopyrimidines for the prevention of fungal pests novel 4-aminopyrimidines method for production thereof and agents comprising the same |
09/14/2006 | WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
09/14/2006 | US20060205772 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type I |
09/14/2006 | US20060205719 Novel compounds having an antibacterial activity |
09/14/2006 | DE102006006251A1 Cyclische Mannich-Produkte Cyclic Mannich products |
09/13/2006 | CN1832933A Method for production of n-aryl morpholinones |
09/13/2006 | CN1832912A Clear photopolymerizable systems for the preparation of high thickness coatings |
09/13/2006 | CN1832761A Thiotungstate analogues and uses thereof |
09/13/2006 | CN1830941A Compound having hydroxycarbonyl-halogenoalkyl side chain |
09/12/2006 | US7105701 Multibinding compounds for agonists for phenolic derivatives for adrenergic receptors with carriers |
09/12/2006 | US7105683 Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates |
09/12/2006 | US7105662 Method of producing N-substituted 2,6-dialkylmorpholines |
09/12/2006 | US7105661 producing nucleic acid (DNA or RNA) fragments enzymatically extended with morpholino-nucleoside triphosphates; dna polymerases |
09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
09/08/2006 | WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators |
09/08/2006 | WO2006077025A3 Morpholines as 5ht2c agonists |
09/08/2006 | CA2599989A1 N-phenyl benzamide derivatives as sirtuin modulators |
09/07/2006 | US20060199957 Novel bicyclic and tricyclic cannabinoids |
09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
09/06/2006 | EP1697353A2 Aralkyl and aralkylidene heterocyclic lactams with affinity for 5-ht1 receptors |
09/06/2006 | EP1517894B1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin antagonists and/or serotonin reuptake inhibitors |
09/06/2006 | CN1829695A Aminoquinoline derivatives and their use as adenosine A3 ligands |
09/05/2006 | USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent |
09/05/2006 | US7101999 Red fluorescence dyes; labels |
09/05/2006 | US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
09/05/2006 | US7101876 Substituted benzoxazines as integrin antagonists |
08/31/2006 | WO2006090235A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
08/31/2006 | WO2006089859A1 Novel drugs for treating respiratory diseases |
08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
08/31/2006 | DE102005008921A1 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen New drugs for the treatment of respiratory disorders |
08/31/2006 | CA2598914A1 Novel drugs for treating respiratory diseases |
08/31/2006 | CA2598518A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
08/30/2006 | EP1694656A1 Benzoxazine derivatives and uses thereof |
08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
08/30/2006 | CN1824659A Synthesis method of butadiene morpholine |
08/30/2006 | CN1272324C Novel herbicides |
08/24/2006 | WO2006088720A2 9-substituted tetracyclines |
08/24/2006 | WO2006087935A1 Pharmaceutical composition containing phenoxazinium compound as active ingredient |
08/24/2006 | CA2597870A1 9-substituted tetracyclines |
08/23/2006 | CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
08/23/2006 | CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
08/17/2006 | WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
08/17/2006 | WO2006085978A2 Conjugates of a cephalosporin derivative and a fluorophor precursor and related compounds as substrates for beta-lactamase gene expression |
08/17/2006 | WO2006084368A1 Fluorinated phno and analogs thereof |
08/17/2006 | WO2006023158A3 Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds |
08/17/2006 | WO2006021213A3 Vasopressin v1a antagonists |
08/17/2006 | WO2006007532A3 2-substituted heteroaryl compounds |
08/17/2006 | US20060183918 Beta 2-adrenergic receptor agonists |
08/17/2006 | US20060183739 Carbonyl compounds |
08/17/2006 | US20060183720 such as (4S,4aS,5aR,12aS)-9-[(N-cyclohexyl-N-hydroxyglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, useful as antimicrobial agents and exhibit antibacterial activity against a wide spectrum of microorganisms |
08/17/2006 | CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
08/17/2006 | CA2597798A1 Fluorinated phno and analogs thereof |
08/16/2006 | EP1689725A1 Resolution process for preparing (+)-(2s, 3s)-2-(3-chlorophenyl)-3,3,3-trimethyl-2-morpholinol |
08/16/2006 | EP1689698A1 Bis-cationic compounds and use thereof |
08/16/2006 | EP1689493A1 Calcitonin gene related peptide receptor antagonists |
08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
08/16/2006 | EP0980362B1 Substituted heterocycles and their use in medicaments |
08/16/2006 | CN1817869A Process for the industrial synthesis of substitute thiophenecarboxydimethylester and application of the compound |
08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
08/10/2006 | WO2006082495A1 Peroxisome proliferator activated receptor modulators |
08/10/2006 | US20060178510 2-Benzyl-substituted: 2-(4-Methoxy-3-trifluoromethyl-benzyl)-morpholine, 2-(4-Methoxy-3-trifluoromethyl-benzyl)-morpholine, 2-[3-Chloro-4-(5-methyl-isoxazol-3-ylmethoxy)-benzyl]-morpholine; lipase inhibitor; central nervous system disorders, antidiabetic agents |
08/10/2006 | US20060178372 Therapeutic quinoline compounds |
08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
08/09/2006 | EP1687638A2 Analysis of mass spectral data in the quiet zones |